Cerni C
Oncology. 1984;41(5):357-62. doi: 10.1159/000225853.
Malignant transformation of cells of an established rat cell line, FR3T3, can be achieved by the exclusive treatment of the cells with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) over a stationary growth period. In the course of the transformation process, sister chromatid exchange (SCE) rates of treated cells were examined at various key-points and compared to control cells. It was found that neither a single TPA treatment nor repeated TPA application during 16-22 consecutive cell-doubling times (which induces substantial alterations of the phenotypes) increased SCE rates in the rat cells. Furthermore, transformed cell clones, which were selected from low-serum cultures and which were found to be tumorigenic in vivo, had SCE rates in the same range as the parental nontransformed FR3T3 cells. It is, therefore, concluded that malignant transformation of the rat cells - induced by TPA - occurs without affecting such large-scale DNA rearrangements as are detectable by means of the SCE method.
通过在稳定生长期用肿瘤启动子12 - O -十四烷酰佛波醇-13 -乙酸酯(TPA)单独处理已建立的大鼠细胞系FR3T3的细胞,可实现其恶性转化。在转化过程中,在各个关键点检测处理细胞的姐妹染色单体交换(SCE)率,并与对照细胞进行比较。结果发现,无论是单次TPA处理还是在连续16 - 22次细胞倍增时间内重复应用TPA(这会诱导表型的实质性改变),都不会增加大鼠细胞的SCE率。此外,从低血清培养物中筛选出的、在体内具有致瘤性的转化细胞克隆,其SCE率与亲代未转化的FR3T3细胞处于相同范围。因此,可以得出结论,TPA诱导的大鼠细胞恶性转化发生时,不会影响通过SCE方法可检测到的大规模DNA重排。